Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04181632 · ClinicalTrials.gov registry record · NA
Evaluation of Pain Alleviating Strategies During Allergy Shots
A NA study, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04181632 is a NA study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 40 participants.
The verdict
NCT04181632, a NA study, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Subcutaneous Immunotherapy (allergy injections) is a potentially disease-modifying therapy that is effective for the treatment of allergic rhinitis/conjunctivitis, allergic asthma and stinging insect hypersensitivity. Pain, which results from the irritation of nearby nerves is a common concern of patients, particularly in children, during or after the injections. This can be a stressful and negative experience for the children. There are various techniques available to minimize pain in general. However, there is a lack of published research on how to use these techniques in children receiving allergy injections. The purpose of this study is to evaluate and compare the efficacy of the standard of care method (Ethyl Chloride/Pain Ease Spray) and three non-pharmacological pain control devices (Buzzy Bee® I, Buzzy Bee II and Shot Blocke®r) in decreasing the perception of pain during subcutaneous allergy injection in a pediatric allergy/immunology clinic setting.
Interventions
- DEVICE Buzzy Bee with Ice pack
- DEVICE Buzzy Bee without Ice pack
- DEVICE Shot Blocker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04181632
The ClinicalTrials.gov registry entry for NCT04181632 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Buzzy Bee with Ice pack is the first listed.
NCT04181632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04181632 about?
NCT04181632 is a clinical study titled "Evaluation of Pain Alleviating Strategies During Allergy Shots". Subcutaneous Immunotherapy (allergy injections) is a potentially disease-modifying therapy that is effective for the treatment of allergic rhinitis/conjunctivitis, allergic asthma and stinging insect hypersensitivity. Pain, which results from the irritation of nearby nerves is a common concern of pa...
What is the current status of trial NCT04181632?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-05-20. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT04181632?
The interventions under investigation include: Buzzy Bee with Ice pack (DEVICE), Buzzy Bee without Ice pack (DEVICE), Shot Blocker (DEVICE).
Who is sponsoring clinical trial NCT04181632?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.